Long before the pandemic outbreak in Wuhan, the global scientific community had been debating the pros and cons of research programs that collect and experiment with potentially dangerous viruses, or experiment with them to explore their possible danger. Those debates have not been resolved. There are still no agreed upon international standards for what sorts of research would pass a risk-benefit test. Any such standards would be technically complex and difficult to monitor across national borders.
